Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Plus Therapeutics (PSTV) Other Non Operating Income (2016 - 2022)

Plus Therapeutics (PSTV) has disclosed Other Non Operating Income for 11 consecutive years, with $1000.0 as the latest value for Q1 2022.

  • Quarterly Other Non Operating Income fell 50.0% to $1000.0 in Q1 2022 from the year-ago period, while the trailing twelve-month figure was $3000.0 through Dec 2022, changed N/A year-over-year, with the annual reading at $1000.0 for FY2022, 83.33% down from the prior year.
  • Other Non Operating Income for Q1 2022 was $1000.0 at Plus Therapeutics, down from $2000.0 in the prior quarter.
  • The five-year high for Other Non Operating Income was $352000.0 in Q1 2018, with the low at -$204000.0 in Q2 2018.
  • Average Other Non Operating Income over 4 years is $41750.0, with a median of $5500.0 recorded in 2018.
  • Peak annual rise in Other Non Operating Income hit 113.33% in 2018, while the deepest fall reached 423.81% in 2018.
  • Over 4 years, Other Non Operating Income stood at $23000.0 in 2018, then skyrocketed by 547.83% to $149000.0 in 2019, then crashed by 98.66% to $2000.0 in 2021, then tumbled by 50.0% to $1000.0 in 2022.
  • According to Business Quant data, Other Non Operating Income over the past three periods came in at $1000.0, $2000.0, and $2000.0 for Q1 2022, Q3 2021, and Q1 2021 respectively.